Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inorganic calcium salts and related mineral deposits, primarily composed of hydroxyapatite and calcium oxalate, serve as physical targets for therapeutic intervention in various pathological conditions [3][5]. In healthy physiology, these minerals provide essential structural support to the skeletal system and teeth; however, their ectopic deposition in soft tissues leads to significant morbidity [2]. Pathological calcification is a hallmark of vascular disease, where hydroxyapatite accumulates in the arterial wall, and nephrolithiasis, where calcium oxalate or phosphate crystals form stones in the urinary tract [1][2]. Drugs targeting these deposits typically work by inhibiting crystal nucleation and growth, chelating calcium ions to increase solubility, or altering the chemical environment to favor mineral dissolution [4]. For example, citrate is used to prevent kidney stone formation by binding calcium in the urine, while novel calcification inhibitors like SNF472 are being developed to target hydroxyapatite crystallization in vascular calciphylaxis [1][4]. Understanding the physical and chemical properties of these mineral deposits is crucial for developing therapies that can selectively target pathological mineralization without compromising healthy bone density [2][5]. Sources: [1] StatPearls: Nephrolithiasis (https://www.ncbi.nlm.nih.gov/books/NBK470365/); [2] Nature Reviews Cardiology: Vascular calcification (https://www.nature.com/articles/s41569-019-0165-5); [3] PubChem: Hydroxyapatite (https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxyapatite); [4] Journal of the American Society of Nephrology: SNF472 (https://jasn.asnjournals.org/content/30/12/2298); [5] NIH: Calcium Oxalate (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044382/).
Drugs targeting these deposits act by inhibiting crystal nucleation, growth, and aggregation, or by chelating calcium ions to increase mineral solubility and facilitate dissolution [1][4].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inorganic calcium salts and related mineral deposits.